← Back to Search

Social support intervention group for Breast Cancer (JLA Trial)

N/A

Recruiting

Led By Qian Lu, PhD; MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Having a first breast cancer diagnosis of stages 0-III

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline before intervention and immediately, 1 month, and 4 months after the intervention

Awards & highlights

JLA Trial Summary

This trial will investigate how a program called Joy Luck Academy can help Chinese American breast cancer survivors by providing them with culturally relevant social support.

Who is the study for?

This trial is for Chinese American breast cancer survivors who are comfortable speaking Mandarin or Cantonese, have had a first diagnosis of stages 0-III breast cancer, and completed primary treatment within the last 36 months.Check my eligibility

What is being tested?

The study tests a culturally based social support program called Joy Luck Academy (JLA) to see how it affects Chinese American women who've survived breast cancer. It's a randomized controlled trial, meaning participants are randomly assigned to receive JLA or not.See study design

What are the potential side effects?

Since this intervention involves social support rather than medication, traditional physical side effects aren't expected. Emotional discomfort due to sharing experiences could occur.

JLA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My first breast cancer diagnosis was at stage 0 to III.

JLA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline before intervention and immediately, 1 month, and 4 months after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline before intervention and immediately, 1 month, and 4 months after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline before intervention and immediately, 1 month, and 4 months after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Quality of life as assessed by Functional Assessment of Cancer Therapy Scale (FACT)

Secondary outcome measures

Change in depressive symptoms as assessed by CES-D

Change in fatigue as assessed by FACIT

Change in positive affect as assessed by the PANAS

+1 more

Other outcome measures

Change in cortisol slope

JLA Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Social support intervention groupExperimental Treatment1 Intervention

The intervention is a 7-week program includes educational and peer mentoring support components. The education curriculum provides information on recognizing side effects of treatment and differentiating them from symptoms of cancer recurrence, physical therapy and alternative treatment, stress management, recognizing depression and managing emotional problems, communication with family members, and body image. The peer-support component assigns each participant with a mentor who is a breast cancer survivor. They share their own experience with participants and also make weekly phone calls to mentees during the intervention to provide support and address remaining concerns.

Group II: Enhanced care and wait-list control groupActive Control1 Intervention

Participants in the control group will receive enhanced usual care while waiting for the JLA program. Participants will be given information booklets in Chinese developed by the American Cancer Society and cover common issues related to breast cancer, various treatments, and life after treatment. Participants will be asked to read through the booklet individually.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,789,308 Total Patients Enrolled

147 Trials studying Breast Cancer

63,118 Patients Enrolled for Breast Cancer

University of California, Los AngelesOTHER

1,532 Previous Clinical Trials

10,265,100 Total Patients Enrolled

8 Trials studying Breast Cancer

1,504 Patients Enrolled for Breast Cancer

Herald Cancer AssociationOTHER

2 Previous Clinical Trials

232 Total Patients Enrolled

2 Trials studying Breast Cancer

232 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"As per clinicaltrials.gov, the current status of this trial indicates that participant recruitment is not ongoing. The trial was initially listed on January 1st, 2015 and last revised on July 9th, 2021. Although enrollment has concluded for this particular study, it's noteworthy that there are currently 2665 other trials actively seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Culturally Sensitive Social Support Intervention

2015. "A Culturally Sensitive Social Support Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02946697.

All > Breast Cancer Anaheim > Breast Cancer